Impact of Anesthesia Monitoring Alarm Sound Level on the Cognitive Load of a Surgical Trainee Using a Simulator
Launched by INSTITUT DE CANCÉROLOGIE DE LORRAINE · Jul 21, 2025
Trial Information
Current as of November 14, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This study is looking at how the volume of anesthesia monitoring alarms in operating rooms affects the mental effort of surgical trainees during simulated surgeries. These alarms are important for patient safety but can sometimes be too loud, which might distract surgeons and make it harder for them to focus. The researchers want to find out if lowering the alarm volume to an optimal level can help reduce this mental strain without making the alarms less effective in keeping patients safe.
The study is open to surgical residents or experienced surgeons who have normal hearing and can perform surgical stitches. Participants will be randomly assigned to work with either a quieter, optimized alarm or a louder standard alarm while performing simulated surgical tasks. The researchers will measure how much mental effort the participants use by looking at things like heart rate and pupil size, as well as asking them about their experience using simple questionnaires. This research aims to improve the working environment in operating rooms, making it easier for surgical teams to focus and learn while keeping patients safe.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Surgical residents or experienced surgeons;
- • Surgeons with normal hearing;
- • Surgeons capable of performing surgical sutures (regardless of skill level);
- • Surgeons able and willing to follow all study procedures according to the protocol;
- • Surgeons who have understood, signed, and dated the informed consent form provided on the day of enrollment.
- Exclusion Criteria:
- • Surgeons undergoing beta-blocker treatment;
- • Surgeons with known cardiac pathology;
- • Surgeons who do not consent to participate in the study;
- • Surgeons with known hearing problems;
- • Surgeons who fail the hearing test;
- • Surgeons who worked on-call or night shifts during the night before the evaluation day.
About Institut De Cancérologie De Lorraine
The Institut de Cancérologie de Lorraine (ICL) is a leading cancer research and treatment center in France, dedicated to advancing oncology through innovative clinical trials and comprehensive patient care. With a focus on multidisciplinary collaboration, ICL integrates cutting-edge research with clinical practice to enhance therapeutic outcomes and improve the quality of life for cancer patients. The institute is committed to fostering scientific discovery and translating findings into effective treatments, while adhering to the highest ethical standards in clinical research. Through its robust portfolio of clinical trials, ICL aims to contribute significantly to the understanding and management of various cancer types.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Frédéric MARCHAL, Pr.
Principal Investigator
Institut de Cancérologie de Lorraine
Nour Mammari Halabi, PhD.
Study Chair
Institut de Cancérologie de Lorraine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported